Eye banking and corneal transplantation communicable adverse incidents: Current status and project NOTIFY

Cornea

Volumn 32, Issue 8, 2013, Pages 1155-1166

  Dubord, Paul J ^a   Evans, G Dewey ⁱ   MacSai, Marian S ^b,c   Mannis, Mark J ^d   Glasser, David B ^e   Strong, Douglas M ^f   Noël, Luc ^g   Fehily, Deirdre ^h  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CHICAGO   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h ISTITUTO SUPERIORE DI SANITÀ   (Italy)

ⁱ NONE

Author keywords

adverse events and reactions; American trypanosomiasis; biovigilance; chikungunya virus; corneal transplantation; Creutzfeldt Jakob disease (CJD); endophthalmitis and microbial keratitis; Eye Bank Technical Advisory Group (EBTAG); hepatitis B and C; herpesviridae; human immunodeficiency virus (HIV) I and II; malignancy; primary graft failure (PGF); project NOTIFY; rabies; syphilis; trypanosoma Cruzi; tuberculosis; West Nile Virus

Indexed keywords

ADENOCARCINOMA; ADVERSE OUTCOME; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BLEEDING; BOVINE SPONGIFORM ENCEPHALOPATHY; BRANCH RETINAL ARTERY OCCLUSION; CANDIDA ALBICANS; CANDIDA ENDOPHTHALMITIS; CHOROIDITIS; CLINICAL EFFECTIVENESS; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; CREUTZFELDT JAKOB DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE TRANSMISSION; ENDOPHTHALMITIS; EYEBANK; FUNGAL ENDOPHTHALMITIS; GRAFT FAILURE; HEALTH CARE FACILITY; HEPATITIS A; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; KERATITIS; KERATOMYCOSIS; LEPROSY; MALARIA; MICROKERATOME; OPTIC NEURITIS; PATIENT MONITORING; PENETRATING KERATOPLASTY; POSTOPERATIVE INFECTION; PRION DISEASE; PRIORITY JOURNAL; RABIES; SMALLPOX; STANDARDIZATION; STREPTOCOCCUS; SURGICAL TECHNIQUE; SYPHILIS; TREATMENT CONTRAINDICATION; TUBERCULOSIS; TYPHOID FEVER; VITRITIS;

COMMUNICABLE DISEASE CONTROL; CORNEAL TRANSPLANTATION; DISEASE TRANSMISSION, INFECTIOUS; EYE BANKS; EYE INFECTIONS; HUMANS; TISSUE AND ORGAN HARVESTING; UNITED STATES;

EID: 84880572901     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31828f9d64     Document Type: Article

References (162)

1. Brubaker S. Maintaining vigilance in the case of exported tissues (from 'anywhere'). In: Nanni A, Noel L, Luc, Strong M, Fehily D (eds): NOTIFY Exploring Vigilance Notification for Organs, Tissues and Cells. Bologna: WHO. 2011:30-31.
2. Eye Bank Association of America. Medical standards. 2011. Available at: http://www.restoresight.org/wp-content/uploads/2011/11/Medical-Standards- October-2011.pdf. Accessed May 15, 2012.
3. European Eye Bank Association. Technical guidelines for ocular tissue. 2012. Available at: http://www.europeaneyebanks.org/files/Technical- Guidelines-Rev5-21-03-2012 GJ-Clean-.pdf Accessed May 15, 2012.
4. U.S. Food and Drug Administration. Guidance for Industry: MedWatch Form FDA 3500A: Mandatory Reporting of Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Available at: http://www.fda.gov/BiologicsBloodVaccines/ SafetyAvailability/ReportaProblem/ ucm153082.htm. Accessed May 15, 2012.
5. Vigilance and Surveillance of Tissues and Cells in the European Union-Final Recommendations of the European Union Standards and Training for the Inspection of Tissue Establishments (EUSTITE) project, June 7, 2010.
6. Sullivan S. Vigilance and Surveillance EUSTITE Pilot Report. Available at: http://www.iss.it/binary/ecet/cont/EUSTITE-VS-Pilot-Report- Final.pdf. Accessed May 15, 2012.
7. World Health Organization. Sixty-third world health assembly, Resolution WHA63.22, Agenda item 11.21, Human organ and tissue transplantation. 2010. Available at: http://apps.who.int/gb/ebwha/pdf-files/ WHA63/A63-R22-en.pdf. x June 3, 2012.
8. World Health Organization (WHO). Aide-Memoire on Key Safety Requirements for Essential Minimally Processed Human Cells and Tissues for Transplantation. Available at: http://www.who.int/transplantation/ AM-SafetyEssential%20HCTT.pdf Accessed June 3, 2012.
9. World Health Organization. Access to Safe and Effective Cells and Tissues for Transplantation, Aide Memoire. 2007. Available at: http://www. who.int/transplantation/AM-HCTTServices.pdf Accessed June 3, 2012.
10. World Health Organization. WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation. Available at: http://www.who.int/ transplantation/Guiding-PrinciplesTransplantation-WHA63.22en.pdf. Accessed June 3, 2012.
11. World Health Organization (WHO) and Centro Nazionale Trapianti (CNT). Report of the Global Consultation for the Project NOTIFY-Exploring Vigilance Notification for Organs Tissues and Cells. Bologna, Italy: Testi Centro Nazionale Trapianti. 2011.
12. World Health Organization (WHO) and Centro Nazionale Trapianti (CNT). Report of the First Global Consultative Meeting on the Bologna Initiative for Global Vigilance and Surveillance. Geneva, Switzerland, 2011.
13. Centers for Disease Control and Prevention (CDC). West Nile virus transmission via organ transplantation and blood transfusion-Louisiana, 2008. MMWR Morb Mortal Wkly Rep. 2009:58:1263-1267. Available at: http:// www.ncbi.nlm.nih.gov/pubmed/19940831. Accessed June 3, 2012.
14. Fauci AS. 2005 Robert H. Ebert memorial lecture emerging and re-emerging infectious diseases: the perpetual challenge. Acad Med. 2005;80:1079-1085.
15. Grossi P. Responding to emerging infectious risks: a national experience and international implications. NOTIFY Exploring Vigilance Notification for Organs, Tissues and Cells: A Global Consultation Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project. 2011:34-35.
16. National Advisory Committee on SARS and Public Health. Learning from SARS: renewal of public health in Canada. 2003. Health Canada.
17. Health Surveillance Coordinating Committee (HSCC). Framework and Tools for Evaluating Health Surveillance Systems. 2004 Centre for Surveillance Coordination, Population & Public Health Branch. Available at: http://www.healthsurv.gc.ca. Accessed June 3, 2012.
18. Kaye S, Baddon A, Jones M, et al. A UK scheme for reporting serious adverse events and reactions associated with ocular tissue transplantation. Cell Tissue Bank. 2010;11:39-46.
19. TRIP (Transfusion Reactions in Patients) Foundation. TRIP annual report 2009 Tissue vigilance-the Netherlands. Available at: http:// www.tripnet.nl/pages/en/documents/MicrosoftWord-ENG-Rapportdef. pdf. Accessed June 3, 2012.
20. Directive 2004/23/EC of the European Parliament and the Council of 31st March 2004 on setting the standards of quality and safety for the donation procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Available at: http://eur-lex. europa.eu/LexUriServ/ LexUriServ.do?uri=OJ: L:2004:102:0048:0058: en:PDF Accessed June 3, 2012.
21. COMMISSION DIRECTIVE 2006/86/EC. Implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union. Available at: http://eur-lex.europa. eu/LexUriServ/LexUriServ.do?uri=OJ: L:2006:294:0032:0050:EN: PDF. Accessed June 3, 2012.
22. Borderie VM. Donor selection, retrieval and preparation of donor tissue. Donor selection. Dev Ophthalmol. 2009;43:22-30.
23. Eastlund T. Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Bank. 2006;7:147-166.
24. Sieck EA, Enzenauer RW, Cornell FM, et al. Contamination of K-Sol corneal storage medium with Propionibacterium acnes. Arch Ophthalmol. 1989;107:1023-1024.
25. Moore PJ, Linnemann CC Jr, Sanitato JJ, et al. Pneumococcal en-dophthalmitis after corneal transplantation: control by modification of harvesting techniques. Infect Control Hosp Epidemiol. 1989;10: 102-105.
26. Cameron JA, Badr IA, Miguel Risco J, et al. Endophthalmitis cluster from contaminated donor corneas following penetrating keratoplasty. Can J Ophthalmol. 1998;33:8-13.
27. Glasser DB. Medical standards for eye banking. Chapter 32. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. 2nd ed. Vol. 1. Fundamentals, Diagnosis and Management. Philadelphia, PA: Elsevier Mosby; 2005:411-420.
28. Hassan SS, Wilhelmus KR, Dahl P, et al; Medical Review Subcommittee of the Eye Bank Association of America. Infectious disease risk factors of corneal graft donors. Arch Ophthalmol. 2008;126: 235-239.
29. Rehany U, Balut G, Lefler E, et al. The prevalence and risk factors for donor corneal button contamination and its association with ocular infection after transplantation. Cornea. 2004;23:649-654.
30. Everts RJ, Fowler WC, Chang DH, et al. Corneoscleral rim cultures: lack of utility and implications for clinical decision-making and infection prevention in the care of patients undergoing corneal transplantation. Cornea. 2001;20:586-589.
31. Wiffen SJ, Hodge DO, Nelson LR, et al. Lysosomal enzymes in corneal storage media and corneal graft outcome. Cornea. 1997;16:169-176.
32. Kloess PM, Stulting RD, Waring GO 3rd, et al. Bacterial and fungal endophthalmitis after penetrating keratoplasty. Am J Ophthalmol. 1993; 115:309-316.
33. Keyhani K, Seedor JA, Shah MK, et al. The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea. 2005; 24:288-291.
34. Wilhelmus KR, Hassan SS. The prognostic role of donor corneoscl-eral rim cultures in corneal transplantation. Ophthalmology. 2007; 114:440-445.
35. Aldave AJ, DeMatteo J, Glasser DB, et al. Report of the Eye Bank Association of America medical advisory board subcommittee on fungal infection after corneal transplantation. Cornea. 2013;32: 149-154.
36. Rauen MP, Goins KM, Sutphin JE, et al. Impact of eye bank lamellar tissue cutting for endothelial keratoplasty on bacterial and fungal cor-neoscleral donor rim cultures after corneal transplantation. Cornea, 2012;31:376-379.
37. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123:613-620.
38. Kernt M, Kampik A. Endophthalmitis: pathogenesis, clinical presentation, management, and perspectives. Clin Ophthalmol. 2010;4: 121-135.
39. Aaberg TM Jr, Flynn HW Jr, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 1998;105:1004-1010.
40. Eifrig CW, Flynn HW Jr, Scott IU, et al. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers. 2002;33:373-378.
41. Wu PC, Kuo HK, Li M, et al. Nosocomial postoperative endophthal-mitis: a 14-year review. Graefes Arch Clin Exp Ophthalmol. 2006;244: 920-929.
42. Fontana L, Parente G, Di Pede B, et al. Candida albicans interface infection after deep anterior lamellar keratoplasty. Cornea. 2007; 26: 883-885.
43. Muzaliha MN, Adil H, Ibrahim M, et al. Candida glabrata endophthal-mitis following penetrating keratoplasty in a patient with negative donor rim culture. BMC Ophthalmol. 2010;10:18. doi:10.1186/1471-2415-10-18.
44. Caldwell MC, Perfect JR, Carlson AN, et al. Candida glabrata endoph-thalmitis following penetrating keratoplasty. J Cataract Refract Surg. 2009;35:598-602.
45. Tappeiner C, Goldblum D, Zimmerli S, et al. Donor-to-host transmission of Candida glabrata to both recipients of corneal transplants from the same donor. Cornea. 2009;28:228-230.
46. Kitzmann AS, Wagoner MD, Syed NA, et al. Donor-related Candida keratitis after Descemet stripping automated endothelial keratoplasty. Cornea. 2009;28:825-828.
47. Aldave AJ. Eye bank reporting system. 50th Anniversary of the Eye Bank Association of America in Tucson, Arizona. September 2011.
48. Gupta G, Feder RS, Lyon AT. Fungal keratitis with intracameral extension following penetrating keratoplasty. Cornea. 2009;28:930-932.
49. Merchant A, Zacks CM, Wilhelmus K, et al. Candidal endophthalmitis after keratoplasty. Cornea. 2001;20:226-229.
50. Sutphin JE, Pfaller MA, Hollis RJ, et al. Donor-to-host transmission of Candida albicans after corneal transplantation. Am J Ophthalmol. 2002; 134:120-121.
51. Al-Assiri A, Al-Jastaneiah S, Al-Khalaf A, et al. Late-onset donor-to-host transmission of Candida glabrata following corneal transplantation. Cornea. 2006;25:123-125.
52. Chew AC, Mehta JS, Li L, et al. Fungal endophthalmitis after Descemet stripping automated endothelial keratoplasty-a case report. Cornea. 2010;29:346-349.
53. Hood CT, Lee BJ, Jeng BH. Incidence, occurrence rate, and characteristics of suture-related corneal infections after penetrating keratoplasty. Cornea. 2011;30:624-628.
54. Das S, Constantinou M, Ong T, et al. Microbial keratitis following corneal transplantation. Clin Experiment Ophthalmol. 2007;35:427-431.
55. de Castro LE, Sarraf OA, Lally JM, et al. Cryptococcus albidus keratitis after corneal transplantation. Cornea. 2005;24:882-883.
56. Eye Bank Association of America. Adverse Reactions Reasonably Likely/Proven to be Due to Donor Tissue (from the Online Adverse Reporting System) Report, June 15, 2011.
57. Bakri SJ, Kaiser PK. Ocular manifestations of West Nile virus. Curr Opin Ophthalmol. 2004;5:537-540.
58. Yahia SB, Khairallah M. Ocular manifestations of West Nile virus infection. Int J Med Sci. 2009;6:114-115.
59. Priestley Y, Thiel M, Koevary SB. Systemic and ophthalmic manifestations of West Nile virus infection. Expert Rev Ophthalmol. 2008;3: 279-292.
60. U.S. Department of Health and Human Services. Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products. August 2007. Available at: http:// www.fda.gov/downloads/ BiologicsBloodVaccines/GuidanceCompliance RegulatoryInformation/Guidances/ Tissue/ucm091345.pdf. Accessed June 15, 2012.
61. Hoft RH, Pflugfelder SC, Forster RK, et al. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea. 1997;16:132-137.
62. Krajden M, Bishai F, Quan C, et al. Multi-organ donor transmission of hepatitis C virus to five solid organ transplant recipients and lack of transmission to corneal transplant recipients. Clin Diagn Virol. 1995;3: 113-121.
63. Sengler U, Reinhard T, Adams O, et al. Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes. Graefes Arch Clin Exp Ophthalmol. 2001;239: 783-787.
64. Lee HM, Naor J, Alhindi R, et al. Detection of hepatitis C virus in the corneas of seropositive donors. Cornea. 2001;20:37-40.
65. Gandhi SS, Lamberts DW, Perry HD. Donor to host transmission of disease via corneal transplantation. Surv Ophthalmol. 1981;25: 306-311.
66. Goldberg MA, Laycock KA, Kinard S, et al. Poor correlation between reactive syphilis serology and human immunodeficiency virus testing among potential cornea donors. Am J Ophthalmol. 1995;119:1-6.
67. Cleator GM, Klapper PE, Dennett C, et al. Corneal donor infection by herpes simplex virus: herpes simplex virus DNA in donor corneas. Cornea. 1994;13:294-304.
68. Cockerham GC, Bijwaard K, Sheng ZM, et al. Primary graft failure: a clinicopathologic and molecular analysis. Ophthalmology. 2000;107: 2083-2090.
69. Borderie VM, Méritet JF, Chaumeil C, et al. Culture-proven herpetic keratitis after penetrating keratoplasty in patients with no previous history of herpes disease. Cornea. 2004;23:118-124.
70. Kaye SB, Baker K, Bonshek R, et al. Human herpesviruses in the cornea. Br J Ophthalmol. 2000;84:563-571.
71. Zhang LJ, Hanff P, Rutherford C, et al. Detection of human cytomeg-alovirus DNA, RNA, and antibody in normal donor blood. J Infect Dis. 1995;171:1002-1006.
72. Holland EJ, Bennett SR, Brannian R, et al. The risk of cytomegalovirus transmission by penetrating keratoplasty. Am J Ophthalmol. 1988;105: 357-360.
73. Suzuki T, Hara Y, Uno T, et al. DNA of cytomegalovirus detected by PCR in aqueous of patient with corneal endotheliitis after penetrating keratoplasty. Cornea. 2007;26:370-372.
74. Sonoyama H, Araki-Sasaki K, Osakabe Y, et al. Detection of cytomeg-alovirus DNA from cytomegalovirus corneal endotheliitis after penetrating keratoplasty. Cornea. 2010;29:683-685.
75. Koizumi N, Yamasaki K, Kawasaki S, et al. Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. Am J Ophthalmol. 2006;141:564-565.
76. Maguire MG. Cytomegalovirus transmission and corneal transplantation. Arch Ophthalmol. 1988;106:877.
77. Kongyai N, Sirirungsi W, Pathanapitoon K, et al. Viral causes of unexplained anterior uveitis in Thailand. Eye (Lond). 2012;26: 529-534.
78. van Boxtel LA, van der Lelij A, van der Meer J, et al. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007;114:1358-1362.
79. Catedral EJ, Santos RE, Padilla MD, et al. Detection of Mycobacterium tuberculosis in corneas from donors with active tuberculosis disease through polymerase chain reaction and culture. Br J Ophthalmol. 2010;94:894-897.
80. Bramante CT, Talbot EA, Rathinam SR, et al. Diagnosis of ocular tuberculosis: a role for new testing modalities? Int Ophthalmol Clin. 2007;47:45-62.
81. Srinivasan M, Prajna L, Prajna NV. A cluster of cases of Mycobacte-rium chelonei keratitis following penetrating keratoplasty. Indian J Ophthalmol. 2005;53:67-68.
82. Chang V, Karp CL, Yoo SH, et al. Mycobacterium abscessus endophthalmitis after Descemet's stripping with automated endothelial keratoplasty. Cornea. 2010;29:586-589.
83. Chaurasia S, Muralidhar R, Garg P, et al. Donor corneal button-related endophthalmitis after penetrating keratoplasty. Clin Experiment Ophthalmol. 2010;38:75-76.
84. Chittum ME, Grutzmacher RD, Oiland DM, et al. Contamination of corneal tissue from infected donors. Arch Ophthalmol. 1985;103:802-804.
85. Clark WM, Heaton KT, Snider GR, et al. Donor eye contamination. Am J Ophthalmol. 1982;94:395-397.
86. Farrell PL, Fan JT, Smith RE, et al. Donor cornea bacterial contamination. Cornea. 1991;10:381-386.
87. Javadi MA, Fayaz A, Mirdehghan SA, et al. Transmission of rabies by corneal graft. Cornea. 1996;15:431-433.
88. Centers for Disease Control and Prevention. Human-to-human transmission of rabies via a corneal transplant-France. MMWR Morb Mortal Wkly Rep. 1980;29:25-26.
89. Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis. 2010;50:1112-1119.
90. Centers for Disease Control and Prevention. Investigation of rabies infections in organ donor and transplant recipients-Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep. 2004; 53;586-589.
91. Caron MJ, Wilson R. Review of the risk of HIV infection through corneal transplantation in the United States. J Am Optom Assoc. 1994;65:173-178.
92. Pepose JS, MacRae S, Quinn TC, et al. Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus. Am J Ophthalmol. 1987;103:798-801.
93. Schwarz A, Hoffmann F, L'age-Stehr J, et al. Human immunodeficiency virus transmission by organ donation. Outcome in cornea and kidney recipients. Transplantation. 1987;44:21-24.
94. Simonds RJ, Holmberg SD, Hurwitz RL, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. NEngl JMed. 1992;326:726-732.
95. Fujikawa LS, Salahuddin SZ, Palestine AG, et al. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet. 1985;2:529-530.
96. Centers for Disease Control and Infection. CJD (Creutzfeldt-Jakob Disease, Classic). Available at: http://www.cdc.gov/ncidod/dvrd/cjd/index. htm. Accessed June 15, 2012.
97. Hogan RN, Cavanagh HD. Transplantation of corneal tissue from donors with diseases of the central nervous system. Cornea. 1995;14:547-553.
98. PHAC. CJD Guideline: Quick Reference Guide-July 2006. Available at: http://www.csao.net/files/pdfs/Quick%20Reference%20Guide%20 with%20Algorythm%20July%2010%20%20final.pdf Accessed June 15, 2012.
99. Cooper JD, Bird SM. Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts. Int J Epidemiol. 2003;32:784-791.
100. Armitage WJ, Tullo AB, Ironside JW. Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation. Eye (Lond). 2009;23:1926-1930.
101. World Health Organization. Variant Creutzfeldt-Jakob disease. Available at: http://www.who.int/mediacentre/factsheets/fs180/en/. Accessed June 15, 2012.
102. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004; 63:417-421.
103. Uchiyama K, Ishida C, Yago S, et al. An autopsy case of Creutzfeldt-Jacob disease associated with corneal transplantation. Dementia. 1994; 8:466-473.
104. Heckmann JG, Lang CJ, Petruch F, et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry. 1997;63:388-390.
105. Bredehorn T, Wilhelm F, Wiederhold C, et al. Incidence of potential transmitters of Creutzfeldt-Jakob disease. A study of a collective of potential cornea donors [in German]. Ophthalmologe. 2001;98: 269-272.
106. Duffy P, Wolf J, Collins G, et al. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974;290: 692-693.
107. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. 2001;358:171-180.
108. Head MW, Northcott V, Rennison K, et al. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease. Invest Ophthalmol Vis Sci. 2003;44:342-346.
109. Hammersmith KM, Cohen EJ, Rapuano CJ, et al. Creutzfeldt-Jakob disease following corneal transplantation. Cornea. 2004;23:406-408.
110. Tullo AB, Buckley RJ, Kelly T, et al. Transplantation of ocular tissue from a donor with sporadic Creutzfeldt-Jakob disease. Clin Experiment Ophthalmol. 2006;34:645-649.
111. Maddox RA, Belay ED, Curns AT, et al. Creutzfeldt-Jakob disease in recipients of corneal transplants. Cornea. 2008;27:851-854.
112. Hogan RN, Brown P, Heck E, et al. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea. 1999;18:2-11.
113. Jirsova K, Krabcova I, Novakova J, et al. The assessment of pathogenic prions in the brains of eye tissue donors: 2-years experience in the Czech Republic. Cornea. 2010;29:996-999.
114. Glasser DB. Serologic testing of cornea donors. Cornea. 1998;17: 123-128.
115. Grandadam M, Caro V, Plumet S, et al. Chikungunya virus, southeastern France. Emerg Infect Dis. 2011;17:910-913.
116. Rezza G, Nicoletti L, Angelini R, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370:1840-1846.
117. UK Blood Transfusion & Tissue Transplantation Services. Available at: http://www.transfusionguidelines.org.uk/Index.aspx?Publication=CTD& Section=17&pageid=5550&AZLetter=C. Accessed June 15, 2012.
118. Herrera L, Martínez C, Carrasco H, et al. Cornea as a tissue reservoir of Trypanosoma cruzi. Parasitol Res. 2007;100:1395-1399.
119. Canadian Blood Service. Call to Action: a strategic plan to improve organ and tissue donation and transplantation performance for Canadians. 2012. Available at: http://www.organsandtissues.ca/s/ wp-content/uploads/2012/06/OTDT- INDX-final-C2A.pdf. Accessed June 15, 2012.
120. McGeorge AJ, Thompson P, Elliot D, et al. Papillary adenocarcinoma of the iris transmitted by corneal transplantation. Cornea. 1994;13:102.
121. López-Navidad A, Soler N, Caballero F, et al. Corneal transplantations from donors with cancer. Transplantation. 2007;83:1345-1350.
122. Morris-Stiff G, Steel A, Savage P, et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant. 2004;4:444-446.
123. Yao X, Lee M, Ying F, et al. Transplanted corneal graft with metastatic cholangiocarcinoma to the donor eye. Eye Contact Lens. 2008;34:340-342.
124. Brederhorn T, Gorsira MC, Volker-Dieben HJ. Post-corneal transplant tumors of nondonor origin in the anterior chamber of the eye: a case report. Cornea. 1998;17:212-214.
125. U.S. Department of health and human services. Guidance for Industry Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Revised December 2011. Available at: http://www.fda. gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ Guidances/default.htm. Accessed June 15, 2012.
126. Shinozaki N, Macsai M, Dubord P. Working group 4-ocular. Part B working group Didactic Papers. In: NOTIFY Exploring Vigilance Notification for Organs, Tissues and Cells A Global Consultation Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project. February 7-9, 2011.
127. Robert PY, Adenis JP, Denis F, et al. Herpesviruses serologic survey of corneal allograft recipients [in French]. J Fr Ophtalmol. 2006;29: 259-263.
128. Biswas S, Suresh P, Bonshek R.E, et al. Graft failure in human donor corneas due to transmission of herpes simplex virus. Br J Ophthalmol. 2000;84:701-705.
129. De Kesel RJ, Koppen C, Ieven M, et al. Primary graft failure caused by herpes simplex virus type 1. Cornea. 2001;20:187-190.
130. Robert PY, Adenis JP, Pleyer U. How "safe" is corneal transplantation? A contribution on the risk of HSV-transmission due to corneal transplantation [in German]. Klin Monbl Augenheilkd. 2005;222:870-873.
131. Robert PY, Adenis JP, Denis F, et al. Transmission of viruses through corneal transplantation. Clin Lab. 2005;51:419-423.
132. Gal RL, Dontchev M, Beck RW, et al. The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology. 2008;115:620-626.
133. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology. 1994;101:1536-1547.
134. Canadian Standards Association (CSA). CAN/CSA.1-103-Cells, Tissues and Organs for Transplantation and Assisted Reproductive: General Requirements; CAN/CSA.2.4.-03-Ocular Tissues for Transplantation. Available at: http://shop.csa.ca/en/canada/transplantation/z900-package/ invt/27031572003/. Accessed June 15, 2012.
135. Robert PY, Adenis JP, Denis F, et al. Transmission of viruses through corneal transplantation. Clin Lab. 2005;51:419-423. Erratum in Clin Lab. 2005;51:608.
136. O'Day DM. Diseases potentially transmitted through corneal transplantation. Ophthalmology. 1989;96:1133-1137;discussion 1137-1138.
137. Toniolo M, Camposampiero D, Griffoni C, et al. Quality management in European eye banks. Dev Ophthalmol. 2009;43:70-86.
138. Hassan SS, Wilhelmus KR. Eye-banking risk factors for fungal endophthalmitis compared with bacterial endophthalmitis after corneal transplantation. Am J Ophthalmol. 2005;139:685-690.
139. Fontana L, Errani PG, Zerbinati A, et al. Frequency of positive donor rim cultures after penetrating keratoplasty using hypothermic and organ-cultured donor corneas. Cornea. 2007; 26: 552-556.
140. Pels E, Rijneveld WJ. Organ culture preservation for corneal tissue. Technical and quality aspects. Dev Ophthalmol. 2009;43:31-46.
141. Pels L. Organ culture: the method of choice for preservation of human donor corneas. Br J Ophthalmol. 1997;81:523-525.
142. Pels E, Beele H, Claerhouts I. Eye bank issues: II Preservation techniques: warm versus cold storage. Int Ophthalmol. 2008;3:155-163.
143. Lindquist TD, Miller TD, Elsen JL, et al; Policy and Position Research Subcommittee of the Medical Advisory Board of the Eye Bank Association of America. Minimizing the risk of disease transmission during corneal tissue processing. Cornea. 2009;28:481-484.
144. Badenoch PR, Coster DJ. Is viral nucleic acid testing of eye donors cost-effective? Med J Aust. 2009;191:408.
145. Heck E, Brown A, Cavanagh HD. Nucleic acid testing and tissue safety: an eye bank's five-year review of HIV and hepatitis testing for donor corneas. Cornea. 2013;32:503-505.
146. Solomon O. SOHO vigilance in the EU. In: Nanni A, Noel L, Luc, Strong M, Fehily D (eds): NOTIFY Exploring Vigilance Notification for Organs, Tissues and Cells. Bologna, WHO; 2011. pp. 17-18.
147. Darlington JK, Adrean SD, Schwab IR. Trends of penetrating kerato-plasty in the United States from 1980 to 2004. Ophthalmology. 2006; 113:2171-2175.
148. Eye Bank Association of America. 2011 Eye Banking Statistical Report. Washington, DC: Eye Bank Association of America, 2012.
149. World Health Organization. WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation. Geneva, Switzerland: World Health Organization; 2010.
150. World Health Organization. Aide-Memoire for National Health Authorities. Available at: http://www.who.int/transplantation/AM-HCTTServices.pdf. Accessed June 15, 2012.
151. Macsai M, Dubord P, Shosaki N. Working group 4-Ocular. Part A and Part B NOTIFY Exploring Vigilance Notification for Organs, Tissues and Cells. Geneva, Switzerland: WHO; 2011.
152. Eye Bank Technical Advisory Group (EBTAG). Available at: http:// www.iccbba.org/committees/technical-advisory-groups/ebtag2. Accessed June 20, 2012.
153. Brubaker SA, Wilson D. Coding and traceability: cells and tissues in North America. Cell Tissue Bank. 2010;11:305-323.
154. Strong M, Shinozaki N. Coding and traceability for cells, tissues and organs for transplantation. Cell Tissue Bank. 2010;11:305-323.
155. Distler P. ISBT 128: a global information standard. Cell Tissue Bank. 2010;11:365-373.
156. Brubaker SA. Tissue tracking failures and lessons learned: hope for the future. GxP Lifeline. 2010.
157. Ashford P. Traceability. Cell Tissue Bank. 2010;11:329-333.
158. SOHO V&S. NOTIFY Working Group Didactic Papers. Available at: http://www.sohovs.org/soho/file.php/1/NOTIFY-report-Part-B.pdf. Accessed June 20, 2012.
159. PHS Biovigilance Working Group. Biovigilance In The United States: Efforts To Bridge A Critical Gap In Patient Safety And Donor Health. Available at: http://www.hhs.gov/ash/bloodsafety/biovigilance/ash-to- acbsa-oct-2009.pdf. Accessed June 20, 2012.
160. Noel L. CT Vigilance and surveillance in WHO. In: Nanni A, Noel L, Luc, Strong M, Fehily D (eds): NOTIFY Exploring Vigilance Notification for Organs, Tissues and Cells. Bologna, WHO; 2011, pp. 16-17.
161. Sanchez P, Heck E, Rivera C, et al. Risk factors for infectious disease in corneal transplant screening. Eye Contact Lens. 2006;32: 124-127.
162. Scardino MK, Hwang SJ, Hanna CL, et al. The postmortem sociomed-ical interview: uncertainty in confirming infectious disease risks of young tattooed donors. Cornea. 2002;21:798-802.